New combo attack on liver Cancer's lung spread
NCT ID NCT07482670
Summary
This study aims to see if a combination of two drugs (camrelizumab and rivoceranib), with or without local treatments like surgery or radiation, can help control advanced liver cancer that has spread to the lungs. It will involve 32 adults who have not had prior treatment for their cancer. Researchers will measure how well the tumors shrink and how long patients live without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATECELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.